Ontogeny of vesicular monoamine transporter mRNAs VMAT1 and VMAT2 - I. The developing rat central nervous system

被引:33
|
作者
Hansson, SR
Hoffman, BJ
Mezey, E
机构
[1] NINDS, Basic Neurosci Program, Bethesda, MD 20892 USA
[2] NIMH, Unit Mol Pharmacol, Lab Cellular & Mol Regulat, Bethesda, MD 20892 USA
来源
DEVELOPMENTAL BRAIN RESEARCH | 1998年 / 110卷 / 01期
关键词
biogenic amines; embryonal development; subventricular zone; basal ganglia; sensory nuclei; limbic system; hypothalamus;
D O I
10.1016/S0165-3806(98)00104-7
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
We used in situ hybridization histochemistry to study the expression of the mRNA of the two vesicular monoamine transporters (VMAT1 and VMAT2) during embryonic and postnatal development of the central nervous system (CNS) in the rat. In the adult rat, VMAT2 mRNA is present exclusively in monoaminergic cell groups of the CNS and VMAT1 mRNA was reported to be present in the adrenal medulla and certain intestinal epithelial cells. In contrast to the above, the expression of VMAT1 mRNA has previously never been detected in the central nervous system. This study shows the first evidence that both transporter molecules are expressed in CNS during ontogenesis. We here demonstrate four main expression patterns detected during development: 1. VMAT2 mRNA expression in monoaminergic neurons of the brainstem beginning as early as embryonic day E13. 2. Expression of VMAT2 mRNA in all major sensory relay nuclei of central nervous system. 3. Go-expression of VMAT1 and VMAT2 mRNA in most limbic structures, basal ganglia, as well as in some hypothalamic nuclei. 4. Exclusive expression of VMAT1 mRNA in the neocortical subventricular zone, in the amygdala at early (E15-18) and late (P1-P28) timepoints, the granular cell layer of cerebellum, and in several brainstem motor nuclei. Based on their distribution during development we suggest that monoamines, released in a controlled fashion, might affect wiring of sensory and also motor circuits. VMAT1 mRNA expression may reflect a specific effect of monoamines in glial differentiation and cerebellar granule cell migration and/or differentiation. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:135 / 158
页数:24
相关论文
共 50 条
  • [31] Structural insights into substrate transport and drug inhibition of the human vesicular monoamine transporter 2 (VMAT2)
    Wu, Di
    Zhao, Yan
    Jiang, Daohua
    FEBS JOURNAL, 2025,
  • [32] Changes in vesicular monoamine transporter (VMAT2) and synaptophysin in rat substantia nigra and prefrontal cortex induced by psychotropic drugs
    Zucker, M
    Weizman, A
    Harel, D
    Rehavi, M
    NEUROPSYCHOBIOLOGY, 2001, 44 (04) : 187 - 191
  • [33] In Vivo Evidence for Low Striatal Vesicular Monoamine Transporter 2 (VMAT2) Availability in Cocaine Abusers
    Narendran, Rajesh
    Lopresti, Brian J.
    Martinez, Diana
    Mason, Neale Scott
    Nimes, Michael
    May, Maureen A.
    Daley, Dennis C.
    Price, Julie C.
    Mathis, Chester A.
    Frank, W. Gordon
    AMERICAN JOURNAL OF PSYCHIATRY, 2012, 169 (01): : 55 - 63
  • [34] Vesicular monoamine transporter 2 (Vmat2) knockdown elicits anxiety-like behavior in zebrafish
    Wang, Yali
    Li, Siyue
    Liu, Wenwen
    Wang, Fen
    Hu, Li-Fang
    Zhong, Zhao-min
    Wang, Han
    Liu, Chun-Feng
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 470 (04) : 792 - 797
  • [35] Tardive dyskinesia: placing vesicular monoamine transporter type 2 (VMAT2) inhibitors into clinical perspective
    Citrome, Leslie
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2018, 18 (04) : 323 - 332
  • [36] Relationship between vesicular monoamine transporter 2 (VMAT2) expression and insulin expression in human pancreas
    Saisho, Yoshifumi
    Butler, Alexandra E.
    Monchamp, Travis
    Galasso, Ryan
    Gurlo, Tatyana
    Harris, Paul E.
    Rizza, Roberta.
    Butler, Peter C.
    DIABETES, 2008, 57 : A46 - A47
  • [37] The effect of chronic lithium and L-DOPA treatments on the expression of the vesicular monoamine transporter (VMAT2) in rat brain
    Zucker, M
    Rehavi, M
    NEUROSCIENCE LETTERS, 1997, : S55 - S55
  • [38] Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata
    Staal, RGW
    Sonsalla, PK
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2000, 293 (02): : 336 - 342
  • [39] Deletion of the vesicular monoamine transporter 1 (vmat1/slc18a1) gene affects dopamine signaling
    Lohoff, Falk W.
    Carr, Gregory V.
    Brookshire, Bethany
    Ferraro, Thomas N.
    Lucki, Irwin
    BRAIN RESEARCH, 2019, 1712 : 151 - 157
  • [40] Identification of Vesicular Monoamine Transporter 2 (vmat2)-Containing O2 Chemoreceptors in the Gills of Zebrafish
    Pan, Wen
    Scott, Angela L.
    Nurse, Colin A.
    Jonz, Michael G.
    FASEB JOURNAL, 2017, 31